Novel treatment paradigms for metastatic uveal melanoma
Cancer Gene Therapy, Published online: 01 December 2022; doi:10.1038/s41417-022-00558-yNovel treatment paradigms for metastatic uveal melanoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 1, 2022 Category: Cancer & Oncology Authors: Sapna P. Patel Steven C. Katz Source Type: research
Cancer-derived exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway
Cancer Gene Therapy, Published online: 25 November 2022; doi:10.1038/s41417-022-00563-1Cancer-derived exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 25, 2022 Category: Cancer & Oncology Authors: Ying Liu Changmou Yang Shisheng Chen Weihao Liu Jingyi Liang Shuhua He Jialiang Hui Source Type: research
PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma
Cancer Gene Therapy, Published online: 25 November 2022; doi:10.1038/s41417-022-00550-6PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 25, 2022 Category: Cancer & Oncology Authors: Xuya Wang Xisen Wang Jiabo Li Jianshen Liang Xiao Ren Debo Yun Jie Liu Jikang Fan Yiming Zhang Jinhao Zhang Xiude Ren Hao Zhang Guanjie Shang Jinzhang Sun Lulu Chen Lei Chen Tao Li Luqing Tong Chen Zhang Shengping Yu Xuejun Yang Source Type: research
A20 interacts with mTORC2 to inhibit the mTORC2/Akt/Rac1 signaling axis in hepatocellular carcinoma cells
Cancer Gene Therapy, Published online: 21 November 2022; doi:10.1038/s41417-022-00562-2A20 interacts with mTORC2 to inhibit the mTORC2/Akt/Rac1 signaling axis in hepatocellular carcinoma cells (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 21, 2022 Category: Cancer & Oncology Authors: Xinyu Wang Ying Xiao Yanlei Dong Zhida Wang Jing Yi Jianing Wang Xiaoyan Wang Huaiyu Zhou Lining Zhang Yongyu Shi Source Type: research
Glimmers of hope for targeting oncogenic KRAS-G12D
Cancer Gene Therapy, Published online: 21 November 2022; doi:10.1038/s41417-022-00561-3Glimmers of hope for targeting oncogenic KRAS-G12D (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 21, 2022 Category: Cancer & Oncology Authors: Daolin Tang Rui Kang Source Type: research
Correction to: The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth
Cancer Gene Therapy, Published online: 18 November 2022; doi:10.1038/s41417-022-00565-zCorrection to: The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 18, 2022 Category: Cancer & Oncology Authors: Elizabeth Proa ño-Pérez Eva Serrano-Candelas Alfonso Garc ía-Valverde Jordi Rosell David G ómez-Peregrina Arnau Navin és-Ferrer Mario Guerrero C ésar Serrano Margarita Mart ín Source Type: research
Carboxyl-terminal modulator protein facilitates tumor metastasis in triple-negative breast cancer
Cancer Gene Therapy, Published online: 18 November 2022; doi:10.1038/s41417-022-00559-xCarboxyl-terminal modulator protein facilitates tumor metastasis in triple-negative breast cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 18, 2022 Category: Cancer & Oncology Authors: Cheng-Han Lin Wen-Der Lin Yun-Chin Huang Yu-Chia Chen Zhu-Jun Loh Luo-Ping Ger Forn-Chia Lin Hao-Yi Li Hui-Chuan Cheng Kuen-Haur Lee Michael Hsiao Pei-Jung Lu Source Type: research
KCNF1 promotes lung cancer by modulating ITGB4 expression
Cancer Gene Therapy, Published online: 16 November 2022; doi:10.1038/s41417-022-00560-4KCNF1 promotes lung cancer by modulating ITGB4 expression (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 16, 2022 Category: Cancer & Oncology Authors: Ching-Yi Chen Pei-Ying Wu Michelle Van Scoyk Stephanie A. Simko Chu-Fang Chou Robert A. Winn Source Type: research
Identification of a novel prognostic ADME-related signature associated with tumor immunity for aiding therapy in head and neck squamous cell carcinoma
Cancer Gene Therapy, Published online: 15 November 2022; doi:10.1038/s41417-022-00557-zIdentification of a novel prognostic ADME-related signature associated with tumor immunity for aiding therapy in head and neck squamous cell carcinoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 15, 2022 Category: Cancer & Oncology Authors: Zhifeng Liu Yuxi Tian Xin Zhang Juncheng Wang Jing Yang Source Type: research
Correction to: Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway
Cancer Gene Therapy, Published online: 15 November 2022; doi:10.1038/s41417-022-00553-3Correction to: Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 15, 2022 Category: Cancer & Oncology Authors: Chang Liu Sijie Li Xiaoxiao Zhang Chunxiang Jin Baofeng Zhao Liying Li Qing Robert Miao Ying Jin Zhimin Fan Source Type: research
The function of brother of the regulator of imprinted sites in cancer development
Cancer Gene Therapy, Published online: 14 November 2022; doi:10.1038/s41417-022-00556-0The function of brother of the regulator of imprinted sites in cancer development (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 14, 2022 Category: Cancer & Oncology Authors: Siqi Zhou Lian Li Ming Zhang Yang Qin Bo Li Source Type: research
EZH1/2 as targets for cancer therapy
Cancer Gene Therapy, Published online: 11 November 2022; doi:10.1038/s41417-022-00555-1EZH1/2 as targets for cancer therapy (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 11, 2022 Category: Cancer & Oncology Authors: Ran An Yu-Qing Li Yue-Ling Lin Fang Xu Man-Mei Li Zhong Liu Source Type: research
Novel long noncoding RNA LINC02820 augments TNF signaling pathway to remodel cytoskeleton and potentiate metastasis in esophageal squamous cell carcinoma
Cancer Gene Therapy, Published online: 10 November 2022; doi:10.1038/s41417-022-00554-2Novel long noncoding RNA LINC02820 augments TNF signaling pathway to remodel cytoskeleton and potentiate metastasis in esophageal squamous cell carcinoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 10, 2022 Category: Cancer & Oncology Authors: Jing Wang Tie-Jun Huang Yan Mei Fei-Fei Luo De-Huan Xie Li-Xia Peng Bao-Qi Liu Mei-Ling Fan Jiang-Bo Zhang Shu-Tao Zheng Chao-Nan Qian Bi-Jun Huang Source Type: research
HIF-1α/IL-8 axis in hypoxic macrophages promotes esophageal cancer progression by enhancing PD-L1 expression
Cancer Gene Therapy, Published online: 10 November 2022; doi:10.1038/s41417-022-00551-5HIF-1α/IL-8 axis in hypoxic macrophages promotes esophageal cancer progression by enhancing PD-L1 expression (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 10, 2022 Category: Cancer & Oncology Authors: Shuai Song Yahui Zhang Xinchun Duan Chunquan Liu Yanlin Du Xiaoran Wang Yi Luo Yong Cui Source Type: research
Rational pemetrexed combined with CIK therapy plus anti-PD-1 mAbs administration sequence will effectively promote the efficacy of CIK therapy in non-small cell lung cancer
Cancer Gene Therapy, Published online: 09 November 2022; doi:10.1038/s41417-022-00543-5Rational pemetrexed combined with CIK therapy plus anti-PD-1 mAbs administration sequence will effectively promote the efficacy of CIK therapy in non-small cell lung cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 9, 2022 Category: Cancer & Oncology Authors: Shaochuan Liu Yuan Meng Liang Liu Yingge Lv Feng Wei Wenwen Yu Limei Wang Xiying Zhang Xiubao Ren Qian Sun Source Type: research
